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Background: Large health care databases are a valuable source of infectious disease epide-
miology if diagnoses are valid. The aim of this study was to investigate the accuracy of the 
recorded diagnosis coding of herpes simplex encephalitis (HSE) in the Danish National Patient 
Registry (DNPR).
Methods: The DNPR was used to identify all hospitalized patients, aged ≥15 years, with a first-
time diagnosis of HSE according to the International Classification of Diseases, tenth revision 
(ICD-10), from 2004 to 2014. To validate the coding of HSE, we collected data from the Danish 
Microbiology Database, from departments of clinical microbiology, and from patient medical 
records. Cases were classified as confirmed, probable, or no evidence of HSE. We estimated 
the positive predictive value (PPV) of the HSE diagnosis coding stratified by diagnosis type, 
study period, and department type. Furthermore, we estimated the proportion of HSE cases 
coded with nonspecific ICD-10 codes of viral encephalitis and also the sensitivity of the HSE 
diagnosis coding.
Results: We were able to validate 398 (94.3%) of the 422 HSE diagnoses identified via the 
DNPR. Hereof, 202 (50.8%) were classified as confirmed cases and 29 (7.3%) as probable cases 
providing an overall PPV of 58.0% (95% confidence interval [CI]: 53.0–62.9). For “Encephalitis 
due to herpes simplex virus” (ICD-10 code B00.4), the PPV was 56.6% (95% CI: 51.1–62.0). 
Similarly, the PPV for “Meningoencephalitis due to herpes simplex virus” (ICD-10 code 
B00.4A) was 56.8% (95% CI: 39.5–72.9). “Herpes viral encephalitis” (ICD-10 code G05.1E) 
had a PPV of 75.9% (95% CI: 56.5–89.7), thereby representing the highest PPV. The estimated 
sensitivity was 95.5%.
Conclusion: The PPVs of the ICD-10 diagnosis coding for adult HSE in the DNPR were 
relatively low. Hence, the DNPR should be used with caution when studying patients with 
encephalitis caused by herpes simplex virus.
Keywords: HSE, viral encephalitis, positive predictive value, validation studies, DNPR, sensitivity
Introduction
Herpes simplex encephalitis (HSE) is the most common form of sporadic encepha-
litis worldwide and remains a disease with high mortality and long-term morbid-
ity.1,2 If untreated, the mortality reaches 70%, and remains ~20% in the case of 
appropriate intravenous acyclovir treatment.3,4 At least 50% of HSE survivors suffer 
from neurological deficits such as aphasia and amnesia.5 The incidence of HSE is 
approximately two to four cases per million population per year.4 In  Sweden, a 
population-based estimate of 2.2 cases per million population per year was  calculated 
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in a nationwide study.6 It is expected that 90% of the cases 
are caused by herpes simplex virus type 1 (HSV-1), and 
~10% are caused by HSV type 2 (HSV-2), the latter more 
often being associated with aseptic meningitis.7 Thus, 
HSE remains a disease requiring continuous investigation 
to better understand the epidemiology, pathogenesis, and 
determinants of prognosis.
Population-based health care databases, such as those 
developed in Denmark, may constitute a cost-effective way 
of conducting epidemiological studies on HSE patients. 
The large size of the databases offers a potential for precise 
estimates even when studying rare outcomes or exposures. 
Typically, the data are collected for administrative purposes, 
and the risk of recall bias and nonresponse bias is therefore 
minimized.8 However, researchers who conduct observational 
studies using existing data are unable to control the data col-
lection and quality. Therefore, the utility of these databases 
relies on the validity of the registered data.
To our knowledge, no previous studies have thoroughly 
validated HSE diagnoses in hospital registries. Hence, the 
aim of this study was to assess the positive predictive value 
(PPV) of the HSE diagnosis coding at patient discharge 
in the population-based Danish National Patient Registry 
(DNPR) using data from medical record reviews and 
microbiological data as a reference standard. Furthermore, 
we wished to estimate the sensitivity of the HSE diagnosis 
coding.
Methods
Data sources
The Danish National Health Service provides universal and 
unrestricted tax-supported health care. This facilitates free 
access to hospitals for all Danish residents. Since 1968, a 
unique ten-digit civil registry number (Civil Personal Reg-
istration [CPR] number) has been assigned to all Danish 
residents by the Danish Civil Registry System.9 The CPR 
number allows accurate and highly valid individual-level 
record linkage of data between Danish registries.10 Our 
study relied upon linkage of data from the DNPR, the Dan-
ish Microbiology Database (MiBa), departments of clinical 
microbiology, and patient medical records.
Danish national Patient registry
The DNPR contains data from all admissions to Danish 
somatic hospitals since 1977, and all visits to emergency 
rooms and outpatient clinics since 1994. The registry contains 
administrative information such as dates of admission and 
discharge, place of admission, and primary and secondary 
diagnosis codes. The diagnoses are coded at patient discharge 
by medical doctors using the Danish version of the Interna-
tional Classification of Diseases, eighth revision (ICD-8) 
(1977–1993), and ICD, tenth revision (ICD-10) (since 1994). 
The diagnoses are subsequently entered in the hospital reg-
istry by a medical secretary and transmitted electronically 
to the DNPR. DNPR data are continuously updated with 
complete nationwide coverage since 1978.11
Danish Microbiology Database
The MiBa is a nationwide, automatically updated data-
base of microbiological test results. Since January 2010, 
all microbiological test reports from the departments of 
clinical microbiology have been transferred electronically 
to MiBa.12
Patient medical records
Information from patient medical records includes record 
notes, radiology descriptions, and results from microbiologi-
cal and biochemical tests.
Identification of coded HSE cases
We searched the DNPR for all patients who received a pri-
mary or secondary diagnosis code indicating HSE (ICD-10 
codes B00.4 “Herpesviral [herpes simplex] encephalitis” 
and B00.4A “Herpesviral [herpes simplex] meningoen-
cephalitis”) during the period of 2004–2014. The majority 
of infectious diseases are coded in the ICD-10 system chap-
ters A00–B99, whereas diseases of the nervous system are 
coded in the chapters G00–G99. The corresponding code 
of B00.4 in the chapters for diseases of the nervous system 
is G05.1 “Encephalitis, myelitis, and encephalomyelitis in 
viral diseases classified elsewhere”. Accordingly, we addi-
tionally included the Danish subcode G05.1E “Herpesviral 
encephalitis” in our study. This code was, however, closed 
on January 1, 2012 in the updated Danish ICD-10 version 
and replaced by G051.U “Encephalitis in viral diseases 
classified elsewhere”.13
To ensure a uniform cohort, pediatric patients (<15 years of 
age) were excluded. Furthermore, only first-time HSE episodes 
were considered. For this reason, we excluded patients with a 
diagnosis code indicating HSE according to both the ICD-10 
(B00.4, B00.4A, G05.1) and ICD-8 classifications (“Menin-
goencephalitis ex herpete simplici” – 054.03) recorded in the 
DNPR before the HSE admissions identified during 2004–2014. 
This was possible by utilizing the complete diagnostic history 
of these patients obtained from the DNPR dating back to 1977.
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Microbiological data and medical record 
validation
To validate the specific diagnoses of HSE, we collected 
data on the patients identified in the DNPR from MiBa, two 
departments of clinical microbiology, and patient medical 
records linked by their CPR numbers. Confirmed HSE was 
primarily defined as a positive finding of HSV-1 DNA by 
polymerase chain reaction (PCR) techniques of the cerebro-
spinal fluid (CSF) samples and/or intrathecal HSV-1 anti-
body production (by enzyme-linked immunosorbent assay 
[ELISA]). The microbiological data on the patients diagnosed 
in the period of 2010–2014 were assessed using MiBa. As far 
as possible, a confirmed microbiological diagnosis of all the 
patients was sought. Therefore, microbiological test results 
of a limited number of patients diagnosed before 2010 were 
obtained from two of the seven microbiological departments 
in Denmark.
We retrieved and reviewed medical records of all the 
remaining patients identified in the DNPR – that is, those 
diagnosed before 2010 – and patients whose diagnosis 
could neither be confirmed nor be disproved by micro-
biological findings. All medical records were reviewed by 
one of the authors (LKJ). Available data including doctor’s 
notes, written radiology reports, and results from labora-
tory tests were assessed. In the majority of the cases, the 
information available was identical with the information 
available to the physician at time of discharge, but in some 
cases, diagnostic information was received shortly after the 
hospital discharge.
If the microbiological findings demonstrated HSV-2 or 
HSV type not specified (HSV-NS) by PCR of the CSF and/or 
intrathecal HSV-2/HSV-NS antibody production, the patients 
had to fulfill at least two of the following additional criteria 
to be considered a confirmed case: 1) acute signs of paren-
chymatous brain dysfunction (focal neurological deficits, 
decreased consciousness, and/or seizures), 2) positive brain 
imaging findings (computed tomography [CT]/magnetic 
resonance imaging [MRI]) of inflammation in frontotemporal 
lobes and/or electroencephalogram findings suggestive of 
encephalitis, and or 3) pleocytosis in CSF (≥5 white blood 
cells/mm3). Patients who according to their medical record 
did not undergo lumbar puncture or had negative microbio-
logical HSV findings, but still fulfilled at least two of the 
aforementioned other criteria, were considered probable cases 
of HSE. The aforementioned inclusion criteria for confirmed 
and probable HSE were based on previously established 
definitions from Granerod et al14 and Persson et al.15 If the 
criteria were not met, or if symptoms were explained by 
another disease, patients were not considered cases of HSE.
Consequently, the cases were classified as “confirmed 
HSE”, “probable HSE”, or “no evidence of HSE”. All cases 
with an uncertain diagnosis based on the information avail-
able were discussed among the authors (LKJ and THM), and 
decisions on confirmation or exclusion of these cases were 
made according to consensus agreement. In cases with dou-
ble-positive microbiological findings of both varicellazoster 
virus (VZV) and HSV, the medical history was evaluated, 
and the cases with additional dermatomal zoster rash were 
excluded, but otherwise, they were considered cases of HSE.
sensitivity analysis
A full evaluation of the sensitivity based on the data sources 
available was not possible. However, to estimate the sensitiv-
ity of the aforementioned HSE diagnoses, we searched the 
DNPR for hospitalized patients aged ≥15 years, who received 
nonspecific encephalitis ICD-10 diagnosis codes from January 
1, 2010 to December 31, 2014. The following ICD-10 codes 
were used: A86.9 “Viral encephalitis without specification”, 
G04.9 “Encephalitis, myelitis and encephalomyelitis, without 
specification”, G04.9A “Encephalitis without specification”, 
and G05.1U “Encephalitis in viral diseases classified else-
where”. Both primary and secondary diagnoses were included. 
If patients subsequently received a HSE-specific diagnosis 
code, they were excluded from this analysis.
To validate the nonspecific diagnoses of viral encepha-
litis, we assessed microbiological data from MiBa of these 
patients. In the analysis regarding coding sensitivity, the 
patients were considered a case of HSE if the MiBa data 
demonstrated positive finding of HSV-1 DNA by PCR of 
the CSF samples or intrathecal HSV-1 antibody production.
statistical analyses
The study outcome was the PPV of HSE diagnoses, defined 
as the proportion of patients with a diagnosis of HSE in the 
DNPR, who had definite and probable HSE according to 
their medical records and microbiological data. The PPV 
was calculated for patients registered by each of the three 
ICD-10 codes indicating HSE and for the whole study popu-
lation. We stratified the PPVs by type of diagnosis (primary 
and secondary), as we expected the PPV to be markedly 
higher for HSE coded as the primary cause of the admission. 
Furthermore, we stratified the PPV by period (2004–2007, 
2008–2011, 2012–2014) to investigate whether the validity 
differed over time and by type of department (infectious 
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diseases and  neurology, as opposed to other departments). 
For each PPV, the corresponding 95% confidence interval 
(CI) was estimated using the method for binomial propor-
tions.16 A chi-square test for linear trend in PPVs over the 
study period was made.
The sensitivity was estimated as the identified confirmed 
cases with HSE-specific diagnosis codes during 2010–2014 
divided by the same cases added with the identified HSE 
cases coded with nonspecific ICD-10 diagnosis codes 
for viral encephalitis. The corresponding 95% CI was 
estimated.
We analyzed the data using Stata Software (v 13.1; 
Stata Corp., College Station, TX, USA). Clinical data from 
medical records were systematically collected using Epi-
Data Software (v 2.0.3.15; EpiData Association, Odense, 
Denmark). The study was approved by the Danish Data 
Protection Agency (journal no 2007-58-0010, case no 1-16-
02-581-14) and authorization to collect the relevant data 
from the medical files was provided by the National Board 
of Health (Journal no 3-3013-886/1). According to Danish 
law, no written informed consent is needed in studies based 
on registry data.
Results
study population
In the DNPR, we identified 422 adult hospital-admitted 
patients with a diagnosis code indicating HSE during 
 2004–2014. None of the patients had previous episodes of 
HSE. The median age of the 422 patients was 60.1 years 
(interquartile range, 43.5–73.2). A total of 228 (54%) were 
female.
Figure 1 schematically shows the validation process of 
the HSE diagnoses. We were able to validate 398 (94.3%) 
of the 422 HSE diagnoses of adult patients identified via the 
DNPR. Of these, 95 (23.9%) of the diagnoses were defined by 
microbiological data from MiBa (n=77, 81.1%) and depart-
ments of microbiology (n=18, 18.9%). From the remaining 
327 patients, we were able to retrieve medical records from 
303 (92.7%). The 24 patients without available medical 
records were sporadically distributed in the different regions 
of  Denmark. Of the 24 patients, 20.8% were diagnosed with 
HSE as a secondary diagnosis but had no other obvious 
similarities that could suggest that they represented a selected 
group of patients. The 24 patients were excluded before the 
analyses because of the missing information.
Nonconfirmed Confirmed HSE
n=23, VZV
+ +
n=71, VZV
n=34, aseptic meningitits
n=10, other diseases
n=29, did not fulfill
enough criteria
Total
n=167
Unable to retrieve
n=24
Probable cases
n=29
Total
n=202
Medical records
n=326
n=75, HSV-1
n=24, HSV-2
n=31, HSV-NS
n=72, HSV-1
DNPR search
n=422
MiBa and 
departments of microbiology
data on n=171
Figure 1 Flowchart illustrating the herpes simplex encephalitis diagnoses validation process.
Abbreviations: DNPR, Danish National Patient Registry; HSE, herpes simplex encephalitis; VZV, varicellazoster virus; HSV, herpes simplex virus; NS, type not specified.
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We classified 202 (50.8%) as being confirmed HSE cases 
and 29 (8.9%) as probable cases of HSE (Figure 1). Thus, 
167 (42.0%) patients were not considered cases of HSE. The 
majority of these (n=94, 56.3%) were instead positive for 
VZV in the CSF. Thirty-four patients (20.4%) more likely 
had viral meningitis as they had no signs of parenchymatous 
brain dysfunction, nonetheless with positive HSV-2 (n=29) 
or HSV-NS (n=5) in the CSF. Ten patients (6%) were misclas-
sified cases in the DNPR. Of these, eight patients had hepatic 
encephalopathy, and two patients had serological findings 
of Borrelia Burgdorferi and Legionella Pneumophila in 
their CSF. Additionally, 29 patients (17.4%) did not meet 
the inclusion criteria to be considered as probable cases 
of HSE. Of these 29 patients, the majority presented with 
clinical signs of parenchymatous brain dysfunction such 
as decreased consciousness or epileptic seizure but lacked 
positive brain imaging findings, and lumbar puncture was 
not performed. These cases may represent several possible 
diseases, that is, other types of viral encephalitis, limbic 
encephalitis, epilepsy, connective tissue diseases, stroke, 
etc. One patient had positive brain imaging showing tem-
poral inflammation on the MRI but lacked other signs of 
parenchymatous brain dysfunction. Likewise, five patients 
had pleocytocis in the CSF but did not fulfill any additional 
criteria. Seven of the patients had a characteristic zoster rash 
but without microbiological findings of VZV in the CSF.
Validation of hsE diagnoses
The results from the validation of the HSE coding are shown 
in Table 1. The overall PPV of the three HSE diagnosis 
codes, including confirmed and probable cases, was 58.0% 
(95% CI: 53.0–62.9). When restricting the HSE definition 
to confirmed cases, the overall PPV of the HSE diagnoses 
in the DNPR was 50.8% (95% CI: 45.7–55.8). The coding 
validity did not differ significantly between the three different 
HSE diagnosis codes.
PPVs of HSE diagnosed in 2004–2007, 2008–2011, 
and 2012–2014 were 56.2% (95% CI: 47.5–64.7), 54.1% 
(95% CI: 46.3–61.8), and 68.1% (95% CI: 57.5–77.5), 
respectively. Although the PPV was highest in 2012–2014, 
the increase was not significant (P-value for trend =0.13). 
The PPVs stratified by type of diagnosis (primary or sec-
ondary) showed no major differences from the overall PPV. 
If the patient was diagnosed at a department of infectious 
diseases or a department of neurology, the PPV was 66.3% 
(95% CI: 60.1–72.1), which was significantly higher than 
the PPV of diagnoses from other departments (43.8%; 95% 
CI: 35.6–52.3).
A total of 635 patients received one of the  aforementioned 
nonspecific diagnosis codes of encephalitis during 2010–
2014. The majority received the diagnosis code “Viral 
encephalitis without specif ication” (A86.9) (n=341, 
53.7%). Among these 635 patients, 27 had HSV in the 
CSF. Five patients had positive HSV-1, seven patients had 
positive HSV-2, and 15 patients had positive HSV-NS. Of 
note, 105 of the confirmed HSE patients (Figure 1) were 
diagnosed during 2010–2014. An approximated estima-
tion of sensitivity is thereby 95.5% (95% CI: 89.7–98.5) 
when only including the HSV-1 positive. If all HSV-positive 
cases with a nonspecified ICD-10 code were true cases of 
Table 1 Positive predictive values for the coding of herpes simplex encephalitis in the DnPr
ICD-10 diagnosis category Positive, na Cases, n Confirmed, n Probable, n PPV (95% CI)
B00.4 “herpesviral (herpes simplex) encephalitis” 332 188 168 20 56.6 (51.1–62.0)
B00.4a “herpesviral (herpes simplex) meningoencephalitis” 37 21 16 5 56.8 (39.5–72.9)
g05.1E “herpesviral encephalitis” 29 22 18 4 75.8 (56.5–89.7)
Combined (B00.4, B00.4a, g05.1E)
 Total 398 231 202 29 58.0 (53.0–62.9)
 Period
  2004–2007 137 77 70 7 56.2 (47.5–64.7)
  2008–2011 170 92 79 13 54.1 (46.3–61.8)
  2012–2014 91 62 53 9 68.1 (57.5–77.5)
 Department type
  iD or n 252 167 147 20 66.3 (60.1–72.1)
  Other 146 64 55 9 43.8 (35.6–52.3)
 Type of diagnosis
  Primary 352 208 186 22 59.1 (53.8–64.3)
  secondary 46 23 16 7 50.0 (34.9–65.1)
Note: aDoes not include the 24 patients whose medical records were not retrievable for validation.
Abbreviations: DNPR, Danish National Patient Registry; ICD-10, International Classification of Diseases, tenth revision; PPV, positive predictive value; CI, confidence 
interval; iD, infectious diseases; n, neurology.
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HSE, the estimated sensitivity would be 79.5% (95% CI: 
71.7–86.1).
Discussion
In this study, we examined the validity of the ICD-10 cod-
ing for HSE in the DNPR. We generally found very low 
PPVs. This result indicates a profound absence of agreement 
between DNPR coding (potentially covering encephalitis 
due to HSV), medical records, and microbiological data. We 
found no variation in the PPV stratified by study period and 
diagnosis type. Our results reveal a higher PPV if the patient 
was diagnosed at a specialized department of neurology 
or infectious diseases versus another medical department. 
Furthermore, we found a relatively high sensitivity of the 
ICD-10 HSE coding in the DNPR.
To our knowledge, there is no previous investigation of the 
validity of the HSE coding in the DNPR. The majority of previ-
ous studies validating ICD-10 diagnosis coding in the DNPR 
have found PPVs of ≥80% using both medical records and labo-
ratory data as reference standard.17–20 Thereby, the PPVs found 
in this study were low as compared to PPV estimates for most 
other diagnoses. Recently, a systematic review investigated the 
data quality and research potential of the DNPR and reported 
substantial variation in the data validity with PPVs varying 
from 15% to 100%.11 This underscores the need of diagnosis 
validation before using data of the DNPR for research.
Attaining a validation rate of 94.3%, the results from 
this study can be considered generalizable to the Danish 
population. However, some limitations need to be considered 
in the interpretation of the results. First, we did not estimate 
the proportion of HSE patients not registered in the DNPR. 
Moreover, some HSE patients may have been registered with 
other diagnosis codes. Thus, full evaluation of the sensitivity, 
specificity, and negative predictive value was not possible. 
However, we did estimate the sensitivity based on identifica-
tion of HSE patients coded with nonspecific ICD-10 codes 
for viral encephalitis. These results revealed a high sensitivity 
of the HSE-specific diagnosis codes. Furthermore, when the 
prevalence is low, the PPV is a good approximation of speci-
ficity.21 Second, only one reviewer (LKJ) evaluated most of 
the medical records, which might have reduced the internal 
validity of the study. However, the inclusion and exclusion 
criteria obtained from the medical records were quite precise 
and objective. Therefore, only few cases ended up with an 
uncertain diagnosis. These were evaluated and discussed by 
several of the authors. Third, we may have  overestimated 
the PPV by including the probable cases. Fourth, 20% of 
the nonconfirmed cases had positive HSV-2 in the CSF but 
no signs of brain parenchymal involvement, and therefore 
did not fulfill the criteria of being cases of HSE. They were, 
instead, considered cases of viral meningitis rather than HSE. 
This decision may underestimate the PPVs of this study 
because cases of mild meningoencephalitis may have been 
excluded. Even if these cases were categorized as cases of 
HSE, the PPV would be <67%. Fifth, cross-reactions between 
VZV and HSV during the serological diagnostic laboratory 
procedures (ELISA) have been reported, which could result 
in an underestimation of the PPV.22 Finally, it is difficult to 
establish consensus among physicians regarding definitions 
of encephalitis, meningoencephalitis, and aseptic meningitis.
The key strengths of this study are the ability to identify 
population-based information in a nationwide cohort and link 
this across several data sources using the Danish CPR number. 
Using these tools, we were able to obtain a high retrieval rate 
of the relevant medical files and construct a suitable refer-
ence standard. Furthermore, we retrieved information during 
an 11-year period. The nationwide cohort with equal access 
to hospital services reduces referral bias. Our definition of 
encephalitis included confirmation of microbiological find-
ings of HSV in the CSF and/or the acute involvement of brain 
parenchyma either by clinical symptoms or by brain imaging 
with findings in frontal or temporal regions characteristic of 
HSE.4 This is a highly reproducible definition, which ensures 
a strict confirmation of this disease. However, this definition 
might be too narrow and thereby contribute to an underesti-
mation of the PPV. The sensitivity and specificity of PCR as a 
diagnostic technique for HSE have been estimated to be 98% 
and 94%, respectively.23 Thereby, we found it reasonable to 
rely solely on verification by microbiological data (if HSV-1 
positive) without reviewing the medical records in these cases.
The low PPVs of the hospital diagnoses of HSE pose some 
potential problems in some analytic and incidence studies, 
perhaps requiring an alternative and/or additional validation 
algorithm. In this context, MiBa serves as a valuable resource 
of microbiological data from 2010 and onward. The authors 
recommend the use of MiBa in future validation studies also 
using microbiological data as part of the reference standard. 
However, the level of data quality needed for registry-based 
studies depends on the research question and study design.24 If 
data are used to compare incidence of HSE over time, the PPV 
should be stable over time.25 We found no significant changes 
in HSE coding validity during the 11-year study period but 
a tendency of an improved coding validity during the last 
2 years of the study period. This may indicate improvement 
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in the use of diagnostic tools with routine use of PCR instead 
of serological analyses. The gold standard for detecting HSV 
in CSF has been PCR throughout the study period. This was 
reflected by the fact that the annual number of incidents was 
stable and no decrease in the number of probable cases was 
observed. This is in contrast to a study by Kadambari et al 
reporting a significant increase in the laboratory-confirmed 
diagnoses of viral meningoencephalitis from 2004 to 2013.26
We found that the miscoding and thereby misclassification 
of HSE ICD-10 codes was substantial both with respect to eti-
ology of encephalitis and the distinction between encephalitis 
and meningitis. More than half of the nonconfirmed cases had 
positive VZV in the CSF. Encephalitis due to VZV is more 
correctly contained by the ICD-10 code B02.0, and therefore, 
this is an example of miscoding by mixing of ICD-10 diagno-
sis codes. Moreover, we did not expect secondary diagnoses 
to have as high PPVs as primary diagnosis, since primary 
diagnosis should reflect the main reason for hospitalization. To 
improve the diagnosis coding of this disease, we recommend 
clinical guidelines for the distinction between encephalitis and 
meningitis emphasizing a combination of several diagnostic 
criteria as described by Granerod et al, which we also used 
in this study.14 Furthermore, more awareness and education 
regarding the diagnosis codes available as well as enhanced 
focus on the importance of precise diagnosis coding is recom-
mended for both physicians and medical secretaries.
Conclusion
We found that the PPVs of the ICD-10 diagnosis coding 
for adult HSE in the DNPR were generally low. Therefore, 
ICD-10 diagnoses of HSE should be used with caution in 
epidemiological research and consolidated by microbiologi-
cal data or information from medical records when possible.
Acknowledgments
The authors would like to thank doctors and secretaries at 
medical departments all over Denmark for their assistance 
with the retrieval of medical records. Furthermore, the 
authors would like to thank the Danish Microbiology Data-
base (MiBa) Board of Representatives and departments of 
clinical microbiology at Aalborg University Hospital and 
Odense University Hospital for providing microbiological 
data. This study was funded by the Novo Nordisk Foundation, 
Denmark (application no 12083, grant area 460). 
Disclosure
THM was supported by a grant from the Medical Research 
Council (DFF-4004-00047). The authors have no other 
 conflicts of interest to declare in this work.
References
 1. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and 
differences in their clinical presentations in England: a multicentre, 
population-based prospective study. Lancet Infect Dis. 2010;10(12): 
835–844.
 2. Whitley RJ. Herpes simplex virus infections of the central nervous 
system. Continuum (Minneap Minn). 2015;21(6):1704–1713.
 3. Whitley RJ, Soong SJ, Dolin R, Galasso GJ, Ch’ien LT, Alford CA. 
Adenine arabinoside therapy of biopsy-proved herpes simplex encepha-
litis. National Institute of Allergy and Infectious Diseases collaborative 
antiviral study. N Engl J Med. 1977;297(6):289–294.
 4. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. 
Antiviral Res. 2006;71(2–3):141–148.
 5. Riancho J, Delgado-Alvarado M, Sedano MJ, Polo JM, Berciano 
J. Herpes simplex encephalitis: clinical presentation, neurological 
sequelae and new prognostic factors. Ten years of experience. Neurol 
Sci. 2013;34(10):1879–1881.
 6. Hjalmarsson A, Blomqvist P, Sköldenberg B. Herpes simplex encepha-
litis in sweden, 1990-2001: incidence, morbidity, and mortality. Clin 
Infect Dis. 2007;45(7):875–880.
 7. Aurelius E, Johansson B, Sköldenberg B, Forsgren M. Encephalitis in 
immunocompetent patients due to herpes simplex virus type 1 or 2 as 
determined by type-specific polymerase chain reaction and antibody 
assays of cerebrospinal fluid. J Med Virol. 1993;39(3):179–186.
 8. Sørensen HT, Lash TL, Rothman KJ. Beyond randomized controlled 
trials: a critical comparison of trials with nonrandomized studies. 
Hepatology. 2006;44(5):1075–1082.
 9. Pedersen CB, Gotzsche H,  Møller JO, Mortensen PB. The Danish Civil 
Registration System. A cohort of eight million persons. Dan Med Bull. 
2006;53(4):441–449.
 10. Frank L. Epidemiology. When an entire country is a cohort. Science. 
2000;287(5462):2398–2399.
 11. Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, 
Sørensen HT. The Danish National Patient Registry: a review of 
content, data quality, and research potential. Clin Epidemiol. 2015;7: 
449–490.
 12. Voldstedlund M, Haarh M, Mølbak K, MiBa Board of Representatives. 
The Danish Microbiology Database (MiBa) 2010 to 2013. Euro Surveill. 
2014;19(1):20667.
13. Sundhedsdatastyrelsen. Koder der lukkes og erstattes af anden kode. 
[Codes that are closed and replaced by other code]. Available from: 
http://sundhedsdatastyrelsen.dk/da/rammer-og-retningslinjer/om-
klassifikationer/sks-klassifikationer/klassifikation-sygdomme/kode-
aendringer. Accessed May 10, 2016. Danish.
 14. Granerod J, Cunningham R, Zuckerman M, et al. Causality in acute 
encephalitis: defining aetiologies. Epidemiol Infect. 2010;138(6): 
783–800.
 15. Persson A, Bergström T, Lindh M, Namvar L, Studahl M. Varicella-
zoster virus CNS disease--viral load, clinical manifestations and sequels. 
J Clin Virol. 2009;46(3):249–253.
 16. Fagan T. Exact 95% confidence intervals for differences in binomial 
proportions. Comput Biol Med. 1999;29(1):83–87.
 17. Blichert-Hansen L, Nielsson MS, Nielsen RB, Christiansen CF, 
 Nørgaard M. Validity of the coding for intensive care admission, 
mechanical ventilation, and acute dialysis in the danish national patient 
registry: a short report. Clin Epidemiol. 2013;5:9–12.
 18. Heden KE, Jensen AO, Farkas DK, Norgaard M. Validity of a procedure 
to identify patients with chronic idiopathic thrombocytopenic purpura 
in the danish national registry of patients. Clin Epidemiol. 2009;1: 
7–10.
 19. Holland-Bill L, Xu H, Sorensen HT, et al. Positive predictive value 
of primary inpatient discharge diagnoses of infection among cancer 
patients in the Danish National Registry of Patients. Ann Epidemiol. 
2014;24(8):593–597, 597.e1–597.e18.
 20. Jespersen CG, Borre M, Norgaard M. Validity of the recorded codes of 
gonadotropin-releasing hormone agonist treatment and orchiectomies in 
the Danish National Patient Registry. Clin Epidemiol. 2012;4:145–149.
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
6.
87
.1
74
 o
n 
07
-F
eb
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Clinical Epidemiology
Publish your work in this journal
Submit your manuscript here: https://www.dovepress.com/clinical‑epidemiology‑journal
Clinical Epidemiology is an international, peer-reviewed, open access, 
online journal focusing on disease and drug epidemiology, identifica-
tion of risk factors and screening procedures to develop optimal pre-
ventative initiatives and programs. Specific topics include: diagnosis, 
prognosis, treatment, screening, prevention, risk factor modification, 
systematic reviews, risk and safety of medical interventions, epidemiol-
ogy and biostatistical methods, and evaluation of guidelines, translational 
medicine, health policies and economic evaluations. The manuscript 
management system is completely online and includes a very quick 
and fair peer-review system, which is all easy to use.
Dovepress
140
Jørgensen et al
 21. Brenner H, Savitz DA. The effects of sensitivity and specificity of case 
selection on validity, sample size, precision, and power in hospital-based 
case-control studies. Am J Epidemiol. 1990;132(1):181–192.
 22. Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365–1376.
 23. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: 
application of polymerase chain reaction to cerebrospinal fluid from 
brain-biopsied patients and correlation with disease. National Institute 
of Allergy and Infectious Diseases Collaborative Antiviral Study Group. 
J Infect Dis. 1995;171(4):857–863.
 24. Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data 
sources for epidemiological research. Int J Epidemiol. 1996;25(2):435–442.
 25. Nørgaard M, Skriver MV, Gregersen H, Pedersen G, Schonheyder HC, 
Sorensen HT. The data quality of haematological malignancy ICD-10 
diagnoses in a population-based hospital discharge registry. Eur J 
Cancer Prev. 2005;14(3):201–206.
 26. Kadambari S, Okike I, Ribeiro S, et al. Seven-fold increase in viral 
meningo-encephalitis reports in England and Wales during 2004-2013. 
J Infect. 2014;69(4):326–332.
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
6.
87
.1
74
 o
n 
07
-F
eb
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
